activated PI3K-delta syndrome
activated PI3K-delta syndrome
Explore linked clinical trials. Standard reference: MONDO:00183383 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pediatric Patients Aged 1 to 6 Years With APDS | activated PI3K-delta syndrome | Active, not recruiting | Phase 3 | 2026-06-15 | NCT05693129 | |
| Pediatric Patients Aged 4 to 11 Years With APDS | activated PI3K-delta syndrome | Active, not recruiting | Phase 3 | 2026-05-06 | NCT05438407 | |
| New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome | activated PI3K-delta syndrome | Recruiting | Not stated | 2026-03-23 | NCT06694363 |